KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $18.9 million.

  • Pacific Biosciences Of California's Cash from Investing Activities fell 1804.9% to $18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.7 million, marking a year-over-year increase of 1835179.23%. This contributed to the annual value of $124.0 million for FY2024, which is 259339.7% up from last year.
  • Pacific Biosciences Of California's Cash from Investing Activities amounted to $18.9 million in Q3 2025, which was down 1804.9% from $25.3 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Cash from Investing Activities registered a high of $242.3 million during Q3 2023, and its lowest value of -$460.8 million during Q2 2021.
  • Its 5-year average for Cash from Investing Activities is -$18.1 million, with a median of $23.1 million in 2024.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 1601780.34% in 2021, then soared by 41472.46% in 2022.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Cash from Investing Activities stood at $65.8 million in 2021, then grew by 22.28% to $80.4 million in 2022, then tumbled by 182.8% to -$66.6 million in 2023, then skyrocketed by 187.48% to $58.2 million in 2024, then plummeted by 67.54% to $18.9 million in 2025.
  • Its last three reported values are $18.9 million in Q3 2025, $25.3 million for Q2 2025, and $45.2 million during Q1 2025.